Dr. Miriam Wolf
About Dr. Miriam Wolf
Dr. Miriam Wolf is the Manager of Study Start-Up and a Clinical Site Manager at Bristol Myers Squibb in München, Bayern, Deutschland. She has extensive experience in clinical research and a strong background in biology, having studied at Ludwig-Maximilians Universität München.
Title at Bristol Myers Squibb
Dr. Miriam Wolf currently holds the position of Manager Study Start-Up at Bristol Myers Squibb in München, Bayern, Deutschland. In this role, she oversees the initiation phases of clinical studies, ensuring that all processes are efficiently managed from study concept to operational execution. Additionally, she serves as a Clinical Site Manager within the same organization, handling site-related clinical operations to ensure compliance and adherence to regulatory and company standards.
Work Experience at Servier
From 2011 to 2017, Dr. Miriam Wolf worked at Servier as a Clinical Research Associate. In this position, she was responsible for overseeing clinical trials, from preparation through to completion, ensuring the proper monitoring and reporting of study data. Her six-year tenure at Servier provided her with significant experience in clinical research methodologies and regulatory requirements.
PhD at Max-Planck Institute for Psychiatry
Dr. Miriam Wolf completed her PhD at the Max-Planck Institute for Psychiatry, where she was engaged as a PhD student from 2008 to 2011. During this period, she focused on psychiatric and neurological research, contributing valuable insights to the field. Her work at the renowned Max-Planck Institute equipped her with deep expertise in scientific research and analysis.
Education and Academic Background
Dr. Miriam Wolf studied biology at Ludwig-Maximilians Universität München, where she earned her Diplom in Biologie, allgemein, from 2001 to 2007. This foundational education in biology set the stage for her subsequent advanced studies and professional endeavors in clinical research.
Start Date at Bristol-Myers Squibb
Dr. Miriam Wolf began her career at Bristol-Myers Squibb in January 2020. Since joining the company, she has taken on key roles in study start-up and clinical site management, contributing her extensive experience and knowledge to the organization's clinical research operations.